Genetic immunization -: Bacteria as DNA vaccine delivery vehicles

被引:23
作者
Becker, Pablo Daniel [1 ]
Noerder, Miriam [1 ]
Guzman, Carlos Alberto [1 ]
机构
[1] Helmholtz Ctr Infect Res, Dept Vaccinol, D-38124 Braunschweig, Germany
来源
HUMAN VACCINES | 2008年 / 4卷 / 03期
关键词
bacterial vectors; DNA vaccine; bactofection; delivery system; live attenuated bacterial carriers;
D O I
10.4161/hv.4.3.6314
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
The so-called DNA vaccination represents one of the most notable tools under development in the field of vaccinology. The concept of administering the gene coding for any given protective antigen and make responsible vaccinee's own cells to produce the protein appeals as too simple to be true. Indeed, the implementation of this approach for mass vaccination should overcome several bottlenecks, such as need of high dosages and poor immunogenicity. In this context, the use of live attenuated bacteria as delivery system for plasmid DNA has emerged as a promising alternative to overcome many of those pitfalls. In addition, this approach is not only amenable for mucosal administration, but allows to specifically target professional antigen presenting cells. This results in their transfection, as well as in their activation and maturation, due to their built-in adjuvant properties resulting from the stimulation of pattern recognition receptors. This chapter discusses the specific features that should be taken into consideration when designing a plasmid vector, current candidate bacterial carriers for DNA delivery and main safety issues.
引用
收藏
页码:189 / 202
页数:14
相关论文
共 220 条
[1]   Yersinia enterocolitica as a vehicle for a naked DNA vaccine encoding Brucella abortus bacterioferritin or P39 antigen [J].
Al-Mariri, A ;
Tibor, A ;
Lestrate, P ;
Mertens, P ;
De Bolle, X ;
Letesson, JJ .
INFECTION AND IMMUNITY, 2002, 70 (04) :1915-1923
[2]   ΔguaBA attenuated Shigella flexneri 2a strain CVD 1204 as a Shigella vaccine and as a live mucosal delivery system for fragment C of tetanus toxin [J].
Anderson, RJ ;
Pasetti, MF ;
Sztein, MB ;
Levine, MM ;
Noriega, FR .
VACCINE, 2000, 18 (21) :2193-2202
[3]  
André S, 1998, J VIROL, V72, P1497
[4]   Pilot study of phoP/phoQ-deleted Salmonella enterica serovar Typhimurium expressing Helicobacter pylori urease in adult volunteers [J].
Angelakopoulos, H ;
Hohmann, EL .
INFECTION AND IMMUNITY, 2000, 68 (04) :2135-2141
[5]   Safety and shedding of an attenuated strain of Listeria monocytogenes with a deletion of actA/plcB in adult volunteers:: a dose escalation study of oral inoculation [J].
Angelakopoulos, H ;
Loock, K ;
Sisul, DM ;
Jensen, ER ;
Miller, JF ;
Hohmann, EL .
INFECTION AND IMMUNITY, 2002, 70 (07) :3592-3601
[6]   Protective efficacy of a plasmid DNA encoding Japanese encephalitis virus envelope protein fused to tissue plasminogen activator signal sequences: studies in a murine intracerebral virus challenge model [J].
Ashok, MS ;
Rangarajan, PN .
VACCINE, 2002, 20 (11-12) :1563-1570
[7]  
ATANASIU P, 1962, CR HEBD ACAD SCI, V254, P2250
[8]   CHARACTERIZATION AND IMMUNOGENICITY OF EX880, A SALMONELLA-TYPHI TY21A-BASED CLONE WHICH PRODUCES VIBRIO-CHOLERAE O-ANTIGEN [J].
ATTRIDGE, SR ;
DEARLOVE, C ;
BEYER, L ;
VANDENBOSCH, L ;
HOWLES, A ;
HACKETT, J ;
MORONA, R ;
LABROOY, J ;
ROWLEY, D .
INFECTION AND IMMUNITY, 1991, 59 (07) :2279-2284
[9]   Induction of a local anti-IpaC antibody response in mice by use of a Shigella flexneri 2a vaccine candidate: Implications for use of IpaC as a protein carrier [J].
Barzu, S ;
Fontaine, A ;
Sansonetti, P ;
Phalipon, A .
INFECTION AND IMMUNITY, 1996, 64 (04) :1190-1196
[10]   Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition [J].
Bauer, S ;
Kirschning, CJ ;
Häcker, H ;
Redecke, V ;
Hausmann, S ;
Akira, S ;
Wagner, H ;
Lipford, GB .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (16) :9237-9242